Co-occurring medical and behavioural conditions in children with Down syndrome with or without ADHD symptom presentation.
ADHD
Behaviour
Co-occurring medical conditions
Down syndrome
Symptoms
Trisomy 21
Journal
Journal of intellectual disability research : JIDR
ISSN: 1365-2788
Titre abrégé: J Intellect Disabil Res
Pays: England
ID NLM: 9206090
Informations de publication
Date de publication:
03 2022
03 2022
Historique:
revised:
01
12
2021
received:
12
08
2021
accepted:
02
12
2021
pubmed:
24
12
2021
medline:
11
5
2022
entrez:
23
12
2021
Statut:
ppublish
Résumé
Co-occurring attention deficit hyperactivity disorder (ADHD) is a challenge to characterise in the presence of other medical conditions commonly present in children with Down syndrome (DS). The current study examined differences among children with DS with or without ADHD symptomatology in terms of demographics, developmental level, co-occurring medical conditions, and parent and teacher ratings of behaviour and executive functioning. Parents and teachers of 108 school-age children with DS provided ratings of ADHD symptoms, behaviour problems and executive functioning skills. Children with DS and ADHD symptom presentation, as identified by a scoring algorithm, were compared with those without ADHD symptom presentation on demographic characteristics, developmental level, co-occurring medical conditions and parent-report and teacher-report measures of behaviours and executive functioning. Sleep disorders, disruptive behaviour disorder, allergies and seizures were more common in children with DS and ADHD symptom presentation than in children without ADHD symptom presentation. After controlling for ADHD medication use, children with DS and ADHD symptom presentation had poorer performance than those without ADHD symptom presentation on parent behaviour ratings, teacher behaviour ratings and parent but not teacher ratings of executive functioning. No significant group differences in demographic characteristics or developmental level were identified. Higher rates of co-occurring medical conditions present in children with DS and ADHD symptom presentation support the need for thorough differential diagnoses. The different pattern of group differences between parent-report and teacher-report has implications for diagnostic practices across settings as well as for treatment.
Sections du résumé
BACKGROUND
Co-occurring attention deficit hyperactivity disorder (ADHD) is a challenge to characterise in the presence of other medical conditions commonly present in children with Down syndrome (DS). The current study examined differences among children with DS with or without ADHD symptomatology in terms of demographics, developmental level, co-occurring medical conditions, and parent and teacher ratings of behaviour and executive functioning.
METHODS
Parents and teachers of 108 school-age children with DS provided ratings of ADHD symptoms, behaviour problems and executive functioning skills. Children with DS and ADHD symptom presentation, as identified by a scoring algorithm, were compared with those without ADHD symptom presentation on demographic characteristics, developmental level, co-occurring medical conditions and parent-report and teacher-report measures of behaviours and executive functioning.
RESULTS
Sleep disorders, disruptive behaviour disorder, allergies and seizures were more common in children with DS and ADHD symptom presentation than in children without ADHD symptom presentation. After controlling for ADHD medication use, children with DS and ADHD symptom presentation had poorer performance than those without ADHD symptom presentation on parent behaviour ratings, teacher behaviour ratings and parent but not teacher ratings of executive functioning. No significant group differences in demographic characteristics or developmental level were identified.
CONCLUSIONS
Higher rates of co-occurring medical conditions present in children with DS and ADHD symptom presentation support the need for thorough differential diagnoses. The different pattern of group differences between parent-report and teacher-report has implications for diagnostic practices across settings as well as for treatment.
Identifiants
pubmed: 34939724
doi: 10.1111/jir.12911
pmc: PMC8816818
mid: NIHMS1761511
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
282-296Subventions
Organisme : NICHD NIH HHS
ID : R61 HD100934
Pays : United States
Organisme : NICHD NIH HHS
ID : R21 HD082307
Pays : United States
Organisme : NICHD NIH HHS
ID : R01 HD093754
Pays : United States
Informations de copyright
© 2021 MENCAP and International Association of the Scientific Study of Intellectual and Developmental Disabilities and John Wiley & Sons Ltd.
Références
Pediatrics. 2019 Oct;144(4):
pubmed: 31570648
J Child Neurol. 2011 Oct;26(10):1290-5
pubmed: 21628698
Am J Ment Defic. 1985 Mar;89(5):485-91
pubmed: 3993694
Arch Gen Psychiatry. 2004 Jul;61(7):731-6
pubmed: 15237085
J Neurodev Disord. 2010 Sep 1;2(3):149-164
pubmed: 21274406
Assessment. 2014 Dec;21(6):694-705
pubmed: 24852496
J Child Psychol Psychiatry. 2004 Nov;45(8):1338-49
pubmed: 15482495
Res Dev Disabil. 2005 Sep-Oct;26(5):456-68
pubmed: 16168883
Pediatrics. 2011 Aug;128(2):393-406
pubmed: 21788214
J Am Acad Child Adolesc Psychiatry. 2003 Aug;42(8):915-22
pubmed: 12874493
Am J Ment Defic. 1983 Jan;87(4):396-402
pubmed: 6829617
J Am Acad Child Adolesc Psychiatry. 2016 Mar;55(3):163-78
pubmed: 26903250
Dev Med Child Neurol. 2017 Mar;59(3):276-283
pubmed: 27503703
Am J Med Genet C Semin Med Genet. 2006 Aug 15;142C(3):158-72
pubmed: 16838318
J Psychiatr Res. 2007 Nov;41(9):795-800
pubmed: 16697412
Eur J Public Health. 2007 Apr;17(2):221-5
pubmed: 16857692
Eur Child Adolesc Psychiatry. 2020 Oct;29(10):1371-1384
pubmed: 31776764
Sci Rep. 2018 Jul 6;8(1):10229
pubmed: 29980754
Pediatr Neurol. 2001 Feb;24(2):99-102
pubmed: 11275457
Am J Ment Retard. 2001 Sep;106(5):416-33
pubmed: 11531461
BMC Psychiatry. 2017 Mar 31;17(1):120
pubmed: 28359274
Sci Rep. 2020 Nov 23;10(1):20345
pubmed: 33230240
Am J Ment Defic. 1985 Mar;89(5):492-502
pubmed: 3158201
Arch Pediatr Adolesc Med. 2007 Sep;161(9):857-64
pubmed: 17768285
J Dev Behav Pediatr. 2015 Oct;36(8):613-9
pubmed: 26035141
J Dev Behav Pediatr. 2013 Feb;34(2):72-82
pubmed: 23363972
J Dev Behav Pediatr. 2020 Feb/Mar;41 Suppl 2S:S35-S57
pubmed: 31996577
J Ment Health Res Intellect Disabil. 2014;7(4):287-305
pubmed: 28539987
J Intellect Disabil Res. 2018 Sep;62(9):785-797
pubmed: 30022564
J Child Psychol Psychiatry. 2013 May;54(5):527-35
pubmed: 22676856
Pediatrics. 2011 Mar;127(3):462-70
pubmed: 21300675
J Atten Disord. 2020 Feb;24(4):509-523
pubmed: 28162039
Eur J Paediatr Neurol. 2015 Sep;19(5):521-4
pubmed: 25976065
Eur Neuropsychopharmacol. 2017 May;27(5):484-493
pubmed: 28336088
J Atten Disord. 2017 Feb;21(3):219-227
pubmed: 23400216
Circulation. 2008 May 6;117(18):2407-23
pubmed: 18427125
J Dev Behav Pediatr. 2013 Feb;34(2):83-93
pubmed: 23363973
Am J Intellect Dev Disabil. 2019 May;124(3):220-233
pubmed: 31026204
Ann Allergy Asthma Immunol. 2004 Jun;92(6):663-7
pubmed: 15237769
Birth Defects Res. 2019 Nov 1;111(18):1420-1435
pubmed: 31580536
Am J Intellect Dev Disabil. 2017 May;122(3):247-281
pubmed: 28452584
Arch Pediatr Adolesc Med. 2008 Apr;162(4):336-42
pubmed: 18391142